Beam Therapeutics BEAM

$ 25.03 6.13%

Quarterly report 2024-Q3
added 11-05-2024

Beam Therapeutics Financial Statements 2011-2024 | BEAM

Annual Financial Statements Beam Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	3.51 B	2.83 B	4.45 B	4.51 B	-	-	-	-	-	-	-	-	-
Shares	77.2 M	70 M	64.2 M	46.7 M	-	-	-	-	-	-	-	-	-
Historical Prices	45.5	40.5	69.2	96.4	-	-	-	-	-	-	-	-	-
Net Income	-133 M	-289 M	-371 M	-195 M	-78.3 M	-115 M	-8 M	-	-	-	-	-	-
Revenue	378 M	60.9 M	51.8 M	24 K	18 K	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-176 M	-338 M	-392 M	-133 M	-75.2 M	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-156 M	-324 M	-385 M	-128 M	-71.7 M	16.2 M	-7.37 M	-	-	-	-	-	-
Operating Expenses	554 M	399 M	444 M	133 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	117 M	87.8 M	57.2 M	29.6 M	20.6 M	11.9 M	2.02 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Beam Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	82.4 M	82.3 M	81.7 M	81.6 M	79 M	76.3 M	72.3 M	71.3 M	70.3 M	70.2 M	68.7 M	68.4 M	66.4 M	62.2 M	60.2 M	57.3 M	50.1 M	49.4 M	30.7 M	7.33 M	6.72 M	6.24 M	5.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-96.7 M	-91.1 M	-98.7 M	-	-96.1 M	-82.8 M	-96.5 M	-	-110 M	-72 M	-69.2 M	-	-28.1 M	-76.3 M	-202 M	-	-34.5 M	-34.2 M	-30.5 M	-	-19 M	-17.9 M	-13.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	14.3 M	11.8 M	7.41 M	-	17.2 M	20.1 M	24.2 M	-	15.8 M	16.7 M	8.43 M	-	763 K	6 K	6 K	-	6 K	6 K	6 K	-	6 K	6 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-107 M	-105 M	-104 M	-	-108 M	-102 M	-98.9 M	-	-91.3 M	-82 M	-76.2 M	-	-69.6 M	-59 M	-200 M	-	-37.3 M	-26.3 M	-28.4 M	-	-18 M	-17.7 M	-13.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-101 M	-99.3 M	-98.7 M	-	-103 M	-97.3 M	-94.3 M	-	-87.8 M	-78.5 M	-72.9 M	-	-64.8 M	-55.9 M	-199 M	-	-33.9 M	-24 M	-27.3 M	-	-17.1 M	-16.8 M	-12.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	121 M	117 M	112 M	-	125 M	122 M	123 M	-	107 M	98.6 M	84.7 M	-	70.4 M	59 M	200 M	-	37.3 M	26.3 M	28.4 M	-	18 M	17.7 M	13.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	26.5 M	29.6 M	26.7 M	-	25.4 M	24.7 M	23.5 M	-	21.8 M	24.1 M	19.2 M	-	15.8 M	13.4 M	10.3 M	-	7.5 M	6.94 M	6.81 M	-	5.49 M	4.98 M	3.93 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency